These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17406130)

  • 21. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity.
    Radley SC; Rosario DJ; Chapple CR; Farkas AG
    J Urol; 2001 Dec; 166(6):2253-8. PubMed ID: 11696746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of urodynamic analysis in patients with benign prostatic enlargement complicated with diabetes mellitus.
    Zhang K; Xu Z; Zhang J; Wang H; Zhang D; Shi B
    Urol Int; 2008; 81(2):149-52. PubMed ID: 18758211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
    Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O
    Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between overactive bladder symptoms and objective parameters from bladder diary and filling cystometry.
    van Brummen HJ; Heintz AP; van der Vaart CH
    Neurourol Urodyn; 2004; 23(1):38-42. PubMed ID: 14694455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonneurogenic voiding disorders in children and adolescents: clinical and videourodynamic findings in 4 specific conditions.
    Glassberg KI; Combs AJ; Horowitz M
    J Urol; 2010 Nov; 184(5):2123-7. PubMed ID: 20850821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer.
    Blaivas JG; Weiss JP; Jones M
    BJU Int; 2006 Dec; 98(6):1233-7; discussion 1237. PubMed ID: 17125481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder sensation measures and overactive bladder.
    Rapp DE; Neil NJ; Govier FE; Kobashi KC
    J Urol; 2009 Sep; 182(3):1050-4. PubMed ID: 19616792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
    Int J Urol; 2004 Jul; 11(7):501-9. PubMed ID: 15242359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Van Venrooij GE; Eckhardt MD; Boon TA
    Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of bladder dysfunction in idiopathic normal pressure hydrocephalus.
    Sakakibara R; Kanda T; Sekido T; Uchiyama T; Awa Y; Ito T; Liu Z; Yamamoto T; Yamanishi T; Yuasa T; Shirai K; Hattori T
    Neurourol Urodyn; 2008; 27(6):507-10. PubMed ID: 18092331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The urodynamic diagnosis of benign prostatic hyperplasia with coexisting overactive bladder].
    Chen Y; DU GH; Chen Z; Cai D; Zhang Q; Yuan XY; Zeng XY; Yang WM; Ye ZQ
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1767-70. PubMed ID: 21211379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different evolution of voiding function in underactive bladders with and without detrusor overactivity.
    Cucchi A; Quaglini S; Rovereto B
    J Urol; 2010 Jan; 183(1):229-33. PubMed ID: 19913829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder sensations during filling cystometry are different according to urodynamic diagnosis.
    Digesu GA; Basra R; Khullar V; Hendricken C; Camarata M; Kelleher C
    Neurourol Urodyn; 2009; 28(3):191-6. PubMed ID: 18973145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia.
    Yamanishi T; Mizuno T; Tatsumiya K; Watanabe M; Kamai T; Yoshida K
    Neurourol Urodyn; 2010 Apr; 29(4):558-62. PubMed ID: 19693954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
    Blaivas JG
    Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple factors related to detrusor overactivity in Chinese patients with benign prostate hyperplasia.
    Liu N; Man LB; He F; Huang GL; Wang H; Li GZ; Wang JW; Lü YW
    Chin Med J (Engl); 2012 Nov; 125(21):3778-81. PubMed ID: 23106872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability of detrusor overactivity on repeated filling cystometry in men with urge symptoms: comparison with spinal cord injury patients.
    Ockrim J; Laniado ME; Khoubehi B; Renzetti R; Finazzi Agrò E; Carter SS; Tubaro A
    BJU Int; 2005 Mar; 95(4):587-90. PubMed ID: 15705085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.